Wpiegulation of macrophage colony-stimulating factor on protease secretion in RAW 264.7 cell and its possible mechanism

Chinese Pharmacological Bulletin

Volumn 22, Issue 8, 2006, Pages 947-951

  Wang, Chun ^a   Xu, Can Xin ^a   Peng, Cui Ying ^a   Qin, Xu Ping ^a   Li, Kai ^a   Liao, Duan Fang ^a  

^a UNIVERSITY OF SOUTH CHINA   (China)

Author keywords

Atherosclerosis; ERK1 2; Macrophage colony stimulating factor; MMP; RAW 264.7

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; COLONY STIMULATING FACTOR 1; GELATIN; GELATINASE B; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEINASE;

ANIMAL CELL; ARTICLE; ATHEROSCLEROSIS; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; ENZYME ACTIVITY; GENE CONTROL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ZYMOGRAPHY;

EID: 33750116125     PISSN: 10011978     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Galis Z S, Sukhova G K, Lark M W, et al. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques[J]. J Clin Invest, 1994,94:2493-503.
2. Brown D L, Hibbs M S, Kearney M, et al. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina[J]. Circulation, 1995,91:2125-31.
3. Loftus I M, Naylor A R, Goodall S. Increased matrix metalloproteinase-9 activity in unstable carotid plaques. A potential role in acute plaque disruption[J]. Stroke, 2000,31(1):40-7.
4. Ferroni P, Basili S, Martini F, et al. Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation[J]. J Investig Med, 2003,51(5):295-300.
5. Jones C B, Sane D C, Herrington D M. Matrix metalloproteinases: a review of their structure and role in acute coronary syndrome [J]. Cardiovasc Res, 2003,59(4):812-23.
6. Pang Z J. Effect of macrophage colony stimulating factor overexpression on oxidative injury/resistance of RAW264. 7 Cells[J]. Clin Exp Med, 2003,3(1):20-6.
7. Mozes G, Mohaesi F, Gloviozki P, et al. Adenovirus-mediated gene transfer of macrophage colony stimulating factor to the arterial wall in vivo[J]. Arterioscler Thromb Vasc Biol, 1998,18:1157-63.
8. Hojo Y, Ikeda U, Takahashi M, et al. Increased levels of monocyte-related cytokines in patients with unstable angina[J]. Atherosclerosis, 2002,161(2):403-8.
9. Rallidis L S, Zolindaki M G, Manioudaki HS, et al. Prognostic value of C-reactive protein, fibrinogen, interleukin-6, and macrophage colony stimulating factor in severe unstable angina[J]. Clin Cardiol, 2002,25(11):505-10.
10. Rallidis L S, Zolindaki M G, Pentzeridis PC, et al. Raised concentrations of macrophage colony stimulating factor in severe unstable angina beyond the acute phase are strongly predictive of long term outcome[J]. Heart, 2004,90(1):25-9.
11. Tojo N, Asakura E, Koyama M, et al. Effects of macrophage colony-stimulating factor (M-CSF) on protease production from monocyte, macrophage and foam cell in vitro: a possible mechanism for anti-atherosclerotic effect of M-CSF[J]. Biochim Biophys Acta, 1999,1452(3):275-84.
12. Pei X H, Nakanishi Y, Takayama K, et al. Granulocyte, granulocyte-macrophage, and macrophage colony-stimulating factors can stimulate the invasive capacity of human lung cancer cells[J]. Br J Cancer, 1999,79(1):40-6.
13. Hiroyasu U, Alice H, Ming L et al. Increased expression of membrane type 3-matrix metalloproteinase in human atherosclerotic plaque: Role of activated acrophages and inflammatory cytokines [J]. Circulation, 2002,106:3024-30.
14. Xu X P, Meisel SR, Ong J M. Oxidized low-density lipoprotein regulates matrix metalloproteinase-9 and its tissue inhibitor in human moncyte-derived macrophages[J] Circulation, 1999,99:993-8.
15. Bellosta S, Via D, Canavesi M, et al. HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages[J]. Arterioscler Thromb Vasc Biol, 1998,18:1671-8.
16. Ruhul Amin A R, Senga T, Oo M L, et al. Secretion of matrix metalloproteinase-9 by the proinflammatory cytokine, IL-1beta: a role for the dual signalling pathways, Akt and Erk[J]. Genes Cells, 2003,8(6):515-23.
17. Li Y M, Feng D M, Li Y S, et al. Effects of AngII and rosatan on expression and activity of MMP2 and MMP9 in cultured SMC from arteriole[J]. Chin Pharmacol Bull, 2003,19(12):1345-9.
18. De Ciuceis C, Amiri F, Brassard P, et al. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-Infused macrophage colony-stimulating factor-deficient mice. Evidence for a role in inflammation in angiotensin-induced vascular injury[J]. Arterioscler Thromb Vasc Biol, 2005,25:2106-13.
19. Dolley C M, McEwan J R, Henny A M. Matrix metalloproteinases and cardiovascular disease[J]. Circ Res, 1995,77:863-8.
20. Galis Z S, Khatri J J. Matrix metalloproteinases in vascular remodeling and atherogenesis: the good, the bad, and the ugly[J]. Circ Res, 2002,90:251-62.
21. JA Hamilton. CSF-I signal transduction: what is of functional significance[J]? Immunol Today, 1997,18(7):313-7.
22. Buscher D, Hipskind R A, Krautwald S, et al. Ras-dependent and-independent pathways target the mitogen-activated protein kinase network in macrophages[J]. Mol Cel Biol, 1995,15(1):466-75.